These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34284106)

  • 1. Synthesis and biological evaluation of platensic alcohol as an adamantane surrogate in antitumor drug lead adaphostin.
    Wen Z; Duan Y; Xiong Y; Huang Y
    Bioorg Med Chem Lett; 2021 Sep; 48():128270. PubMed ID: 34284106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
    Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of adamantane based highly potent HDAC inhibitors.
    Gopalan B; Ponpandian T; Kachhadia V; Bharathimohan K; Vignesh R; Sivasudar V; Narayanan S; Mandar B; Praveen R; Saranya N; Rajagopal S; Rajagopal S
    Bioorg Med Chem Lett; 2013 May; 23(9):2532-7. PubMed ID: 23538115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.
    Le SB; Hailer MK; Buhrow S; Wang Q; Flatten K; Pediaditakis P; Bible KC; Lewis LD; Sausville EA; Pang YP; Ames MM; Lemasters JJ; Holmuhamedov EL; Kaufmann SH
    J Biol Chem; 2007 Mar; 282(12):8860-72. PubMed ID: 17213201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of N-hydroxypropenamides based on adamantane to overcome resistance in NSCLC.
    Bao X; Sun Y; Bao C; Zhang J; Zou S; Yang J; Wu C; Wang L; Chen G
    Bioorg Chem; 2019 May; 86():696-704. PubMed ID: 30831531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1.
    Long J; Manchandia T; Ban K; Gao S; Miller C; Chandra J
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):527-35. PubMed ID: 16924499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaphostin and other anticancer drugs quench the fluorescence of mitochondrial potential probes.
    Le SB; Holmuhamedov EL; Narayanan VL; Sausville EA; Kaufmann SH
    Cell Death Differ; 2006 Jan; 13(1):151-9. PubMed ID: 16052237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1.
    Fer ND; Shoemaker RH; Monks A
    J Exp Clin Cancer Res; 2010 Jul; 29(1):91. PubMed ID: 20618971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
    Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R
    Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
    Shanafelt TD; Lee YK; Bone ND; Strege AK; Narayanan VL; Sausville EA; Geyer SM; Kaufmann SH; Kay NE
    Blood; 2005 Mar; 105(5):2099-106. PubMed ID: 15388586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism.
    Dasmahapatra G; Rahmani M; Dent P; Grant S
    Blood; 2006 Jan; 107(1):232-40. PubMed ID: 16166589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors.
    Cincinelli R; Musso L; Giannini G; Zuco V; De Cesare M; Zunino F; Dallavalle S
    Eur J Med Chem; 2014 May; 79():251-9. PubMed ID: 24742384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy.
    Zhang XJ; Liu MH; Luo YS; Han GY; Ma ZQ; Huang F; Wang Y; Miao ZY; Zhang WN; Sheng CQ; Yao JZ
    Eur J Med Chem; 2021 May; 217():113363. PubMed ID: 33744687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents.
    Cheng J; Qin J; Guo S; Qiu H; Zhong Y
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4768-4772. PubMed ID: 25182565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.
    El-Awady R; Saleh E; Hamoudi R; Ramadan WS; Mazitschek R; Nael MA; Elokely KM; Abou-Gharbia M; Childers WE; Srinivasulu V; Aloum L; Menon V; Al-Tel TH
    Bioorg Med Chem; 2021 Jul; 42():116251. PubMed ID: 34116381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis identifies oxidative stress induction by adaphostin.
    Stockwin LH; Bumke MA; Yu SX; Webb SP; Collins JR; Hollingshead MG; Newton DL
    Clin Cancer Res; 2007 Jun; 13(12):3667-81. PubMed ID: 17575232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines.
    Barnes DJ; De S; van Hensbergen P; Moravcsik E; Melo JV
    Leukemia; 2007 Mar; 21(3):421-6. PubMed ID: 17252018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
    Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.
    Chen YJ; Wang JJ; Chang LS
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors.
    Gong G; Qi J; Lv Y; Dong S; Cao C; Li D; Zhao R; Li Z; Chen X
    Chem Pharm Bull (Tokyo); 2020; 68(5):466-472. PubMed ID: 32378544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.